Northern Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Buy
1,237,752
+25,779
+2% +$614K ﹤0.01% 1422
2025
Q4
$28.3M Sell
1,211,973
-51,915
-4% -$1.16M ﹤0.01% 1447
2025
Q3
$24.9M Sell
1,263,888
-11,202
-0.9% -$230K ﹤0.01% 1542
2025
Q2
$27.7M Sell
1,275,090
-211,108
-14% -$4.98M ﹤0.01% 1457
2025
Q1
$36M Sell
1,486,198
-17,368
-1% -$391K 0.01% 1284
2024
Q4
$31.4M Buy
1,503,566
+119,766
+9% +$2.57M ﹤0.01% 1423
2024
Q3
$27.5M Sell
1,383,800
-2,907
-0.2% -$53.9K ﹤0.01% 1429
2024
Q2
$21.5M Sell
1,386,707
-43,041
-3% -$670K ﹤0.01% 1512
2024
Q1
$22.8M Buy
1,429,748
+11,007
+0.8% +$166K ﹤0.01% 1506
2023
Q4
$23.8M Sell
1,418,741
-18,424
-1% -$252K ﹤0.01% 1487
2023
Q3
$16.8M Buy
1,437,165
+30,262
+2% +$405K ﹤0.01% 1672
2023
Q2
$18.9M Buy
1,406,903
+14,248
+1% +$205K ﹤0.01% 1622
2023
Q1
$23.1M Sell
1,392,655
-1,659
-0.1% -$27.4K ﹤0.01% 1461
2022
Q4
$25.9M Buy
1,394,314
+27,453
+2% +$423K 0.01% 1377
2022
Q3
$17.5M Buy
1,366,861
+50,729
+4% +$601K ﹤0.01% 1584
2022
Q2
$9.23M Sell
1,316,132
-3,761
-0.3% -$27.6K ﹤0.01% 2088
2022
Q1
$10.9M Sell
1,319,893
-58,547
-4% -$414K ﹤0.01% 2087
2021
Q4
$9.33M Sell
1,378,440
-47,263
-3% -$311K ﹤0.01% 2277
2021
Q3
$7.56M Buy
1,425,703
+1,555
+0.1% +$8.5K ﹤0.01% 2471
2021
Q2
$8.19M Buy
1,424,148
+249,975
+21% +$1.29M ﹤0.01% 2511
2021
Q1
$5.41M Sell
1,174,173
-78,168
-6% -$311K ﹤0.01% 2698
2020
Q4
$4.18M Sell
1,252,341
-77,290
-6% -$260K ﹤0.01% 2782
2020
Q3
$3.95M Sell
1,329,631
-49,069
-4% -$192K ﹤0.01% 2682
2020
Q2
$6.37M Buy
1,378,700
+147,737
+12% +$664K ﹤0.01% 2366
2020
Q1
$4.74M Sell
1,230,963
-4,958
-0.4% -$20.4K ﹤0.01% 2328
2019
Q4
$4.63M Buy
1,235,921
+45,009
+4% +$210K ﹤0.01% 2629
2019
Q3
$6.32M Buy
1,190,912
+33,170
+3% +$177K ﹤0.01% 2412
2019
Q2
$4.44M Buy
1,157,742
+30,398
+3% +$131K ﹤0.01% 2622
2019
Q1
$5.75M Sell
1,127,344
-1,297
-0.1% -$3.81K ﹤0.01% 2478
2018
Q4
$2.17M Sell
1,128,641
-25,697
-2% -$73.6K ﹤0.01% 3002
2018
Q3
$4.36M Buy
1,154,338
+46,394
+4% +$145K ﹤0.01% 2762
2018
Q2
$3.46M Buy
1,107,944
+97,997
+10% +$297K ﹤0.01% 2899
2018
Q1
$2.41M Buy
1,009,947
+185,639
+23% +$617K ﹤0.01% 3005
2017
Q4
$3.22M Buy
824,308
+12,795
+2% +$42.3K ﹤0.01% 2858
2017
Q3
$2.04M Buy
811,513
+8,947
+1% +$24.5K ﹤0.01% 3160
2017
Q2
$2.21M Buy
802,566
+691,238
+621% +$1.44M ﹤0.01% 3112
2017
Q1
$217K Buy
111,328
+10,932
+11% +$13.9K ﹤0.01% 3771
2016
Q4
$105K Sell
100,396
-27,188
-21% -$31.1K ﹤0.01% 3888
2016
Q3
$139K Buy
127,584
+37,217
+41% +$33.5K ﹤0.01% 3818
2016
Q2
$64K Sell
90,367
-673,453
-88% -$542K ﹤0.01% 3975
2016
Q1
$893K Sell
763,820
-288
-0% -$447 ﹤0.01% 3291
2015
Q4
$1.87M Buy
764,108
+595
+0.1% +$1.7K ﹤0.01% 3095
2015
Q3
$2.29M Buy
763,513
+621,185
+436% +$2.68M ﹤0.01% 2969
2015
Q2
$588K Buy
142,328
+45,899
+48% +$183K ﹤0.01% 3519
2015
Q1
$418K Sell
96,429
-525
-0.5% -$1.89K ﹤0.01% 3657
2014
Q4
$288K Buy
96,954
+7,540
+8% +$20.7K ﹤0.01% 3704
2014
Q3
$297K Sell
89,414
-2,228
-2% -$5.82K ﹤0.01% 3715
2014
Q2
$232K Buy
91,642
+14,856
+19% +$31.7K ﹤0.01% 3816
2014
Q1
$174K Buy
76,786
+10,743
+16% +$22.5K ﹤0.01% 3821
2013
Q4
$129K Buy
66,043
+10,158
+18% +$20.5K ﹤0.01% 3818
2013
Q3
$171K Buy
55,885
+12,979
+30% +$21.8K ﹤0.01% 3696
2013
Q2
$38K Buy
+42,906
New +$34.3K ﹤0.01% 3958

Other funds holding CPRX